Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iHumanIH -9.42%56 3-Year EBITDA Growth Rate is -15.20% as of Mar. 2026. GuruFocus rates IH with a GF Score™ of 56/100 and a GF Value™ of $1.84 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 196 Education companies, iHuman ranks worse than 82.65% on this metric.
During the past 12 months, iHuman's average EBITDA Per Share Growth Rate was -53.30% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -15.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of iHuman was -15.20% per year. The lowest was -26.30% per year. And the median was -20.75% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
iHuman 3-Year EBITDA Growth Rate Related Terms
IH vs SKIL, COE, STG: 3-Year EBITDA Growth Rate Comparison
For the Education & Training Services subindustry, iHuman's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iHuman 3-Year EBITDA Growth Rate vs Education Industry
For the Education industry and Consumer Defensive sector, iHuman's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where iHuman's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -15.20% mean?
iHuman (IH) has a 3-Year EBITDA Growth Rate of -15.20% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for iHuman and its competitors. According to the industry distribution chart, iHuman ranks #162 out of 196 companies in the Education industry, placing it in the top 82.7%.
Is iHuman's 3-Year EBITDA Growth Rate too high?
iHuman's current 3-Year EBITDA Growth Rate is -15.20%. Based on the distribution chart, iHuman ranks #162 out of 196 companies in the Education industry, which is in the bottom quartile relative to peers. Overall, iHuman has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iHuman's 3-Year EBITDA Growth Rate compare to SKIL and COE?
According to the Education industry distribution chart, iHuman ranks #162 out of 196 companies for 3-Year EBITDA Growth Rate. This places iHuman in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Education company?
The median 3-Year EBITDA Growth Rate among Education companies is 8.30, based on 196 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for iHuman and its competitors. For the Education industry, the median 3-Year EBITDA Growth Rate is 8.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iHuman's current 3-Year EBITDA Growth Rate is -15.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iHuman stock overvalued right now?
Based on GuruFocus' analysis, iHuman (IH) is currently considered Significantly Undervalued. The stock's GF Value™ is $1.84, compared to a current price of $1.25 — trading 32.1% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -15.20%. iHuman's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For iHuman (IH), the current 3-Year EBITDA Growth Rate is -15.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iHuman (IH) Overvalued in 2026?
Based on GuruFocus' analysis, iHuman stock appears to be undervalued.
The current stock price of $1.25 is trading 32.1% below its estimated GF Value™ of $1.84.
GuruFocus considers iHuman to be Significantly Undervalued.
Key valuation signals for IH:
3-Year EBITDA Growth Rate: -15.20%
GF Value™: $1.84 vs. price of $1.25 (32.1% below fair value)
No single metric tells the full story. See the IH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.
56GF Score
Get the complete analysis for IH
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IH has been successfully added to your 
